Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | XIAP | P98170 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14895058 | 0.81 | HTT (0.44) | HTT | |
| SCHEMBL16463249 | 0.79 | HPGD (0.41) | CYP1A2HPGDHTTALDH1A1MEN1 | |
| SCHEMBL16463252 | 0.79 | HPGD (0.41) | CYP1A2HPGDHTTALDH1A1MEN1 | |
| SCHEMBL28337648 | 0.78 | CYP1A2 (0.41) | CYP1A2PKMALPIPTGS1XIAP | |
| SCHEMBL12036068 | 0.78 | CYP1A2 (0.41) | CYP1A2PKMALPIPTGS1XIAP | |
| SCHEMBL2225629 | 0.78 | CYP1A2 (0.41) | CYP1A2PKMALPIPTGS1XIAP | |
| SCHEMBL2225625 | 0.78 | CYP1A2 (0.41) | CYP1A2PKMALPIPTGS1XIAP | |
| SCHEMBL1511639 | 0.78 | CYP1A2 (0.41) | CYP1A2PKMALPIPTGS1XIAP | |
| SCHEMBL17866915 | 0.75 | PKM (0.39) | CYP1A2PKMALDH1A1ALPIPTGS1 | |
| SCHEMBL29312988 | 0.74 | LMNA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2771315-B1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE beta-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE gamma-HYDROXY-URETHANE UNIT | SOCIÉTÉ D EXPL GÉNÉRALE DE PRODUITS IND S E G SAS (FR) | 2016-04-13 | — | — | EP | disclosed |
| US-20140378648-A1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE BETA-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE UPSILON-HYDROXY-URETHANE UNIT | SOULES AURÉLIEN (FR) | 2014-12-25 | — | — | US | disclosed |
| EP-2771315-A1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE beta-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE gamma-HYDROXY-URETHANE UNIT | Societe d'Exploitation Generale de Produits Industriels - S.E.G (SAS) (FR) | 2014-09-03 | — | — | EP | disclosed |
| WO-2013060950-A1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE β-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE ϒ-HYDROXY-URETHANE UNIT | SOCIETE D'EXPLOITATION GENERALE DE PRODUITS INDUSTRIELS - S.E.G. (SAS) (FR) | 2013-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378648-A1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE BETA-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE UPSILON-HYDROXY-URETHANE UNIT | OTUB1, UCHL1, UBE2E1 | CYP1A2 852/4885HPGD 1201/4885HTT 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.